Invention Grant
- Patent Title: Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof
-
Application No.: US16418420Application Date: 2019-05-21
-
Publication No.: US11466082B2Publication Date: 2022-10-11
- Inventor: Michael Diem , Francois Gaudet , Ronan McDaid , Priyanka Nair-Gupta
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Riverside Law LLP
- Main IPC: A61P35/02
- IPC: A61P35/02 ; C07K16/28 ; A61K47/68 ; A61P35/00 ; C07K16/46 ; A61K39/00
Abstract:
Anti-CD33 antibodies and antigen-binding fragments thereof and anti-CD33/anti-CD3 bispecific antibodies or antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer.
Public/Granted literature
- US20190382481A1 ANTI-CD33 ANTIBODIES, ANTI-CD33/ANTI-CD3 BISPECIFIC ANTIBODIES AND USES THEREOF Public/Granted day:2019-12-19
Information query
